Cramer Rosenthal McGlynn’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.4M | Buy |
137,562
+1,653
| +1% | +$217K | 1.21% | 33 |
|
|
2025
Q4 | $18.5M | Sell |
135,909
-693
| -0.5% | -$99.7K | 1.19% | 34 |
|
|
2025
Q3 | $20.1M | Buy |
136,602
+828
| +0.6% | +$115K | 1.25% | 30 |
|
|
2025
Q2 | $17.6M | Buy |
135,774
+18,931
| +16% | +$2.29M | 1.21% | 33 |
|
|
2025
Q1 | $14M | Sell |
116,843
-74,967
| -39% | -$9.29M | 1% | 44 |
|
|
2024
Q4 | $22.3M | Buy |
191,810
+21,647
| +13% | +$2.74M | 1.26% | 31 |
|
|
2024
Q3 | $23M | Buy |
170,163
+7,713
| +5% | +$1.03M | 1.28% | 37 |
|
|
2024
Q2 | $22M | Sell |
162,450
-552
| -0.3% | -$75.1K | 1.29% | 33 |
|
|
2024
Q1 | $21.1M | Buy |
+163,002
| New | +$19.7M | 1.14% | 42 |
|
|
2019
Q4 | – | Sell |
-309,637
| Closed | -$24.7M | – | 122 |
|
|
2019
Q3 | $24.7M | Sell |
309,637
-60,355
| -16% | -$4.74M | 0.7% | 58 |
|
|
2019
Q2 | $30.9M | Sell |
369,992
-144,676
| -28% | -$11.5M | 0.85% | 51 |
|
|
2019
Q1 | $40.7M | Sell |
514,668
-63,274
| -11% | -$4.62M | 0.97% | 37 |
|
|
2018
Q4 | $38.6M | Sell |
577,942
-33,542
| -5% | -$2.32M | 0.97% | 40 |
|
|
2018
Q3 | $48.8M | Sell |
611,484
-101,868
| -14% | -$7.61M | 0.93% | 44 |
|
|
2018
Q2 | $48.1M | Sell |
713,352
-30,857
| -4% | -$2.24M | 0.86% | 54 |
|
|
2018
Q1 | $57.2M | Sell |
744,209
-46,180
| -6% | -$3.41M | 0.94% | 43 |
|
|
2017
Q4 | $53.9M | Sell |
790,389
-57,922
| -7% | -$3.85M | 0.87% | 47 |
|
|
2017
Q3 | $53.1M | Sell |
848,311
-365,094
| -30% | -$21.8M | 0.85% | 46 |
|
|
2017
Q2 | $67.3M | Buy |
1,213,405
+3,171
| +0.3% | +$165K | 1.03% | 27 |
|
|
2017
Q1 | $60.8M | Buy |
1,210,234
+171,346
| +16% | +$8.35M | 0.93% | 32 |
|
|
2016
Q4 | $51.4M | Buy |
1,038,888
+695,127
| +202% | +$35.2M | 0.76% | 53 |
|
|
2016
Q3 | $18M | Sell |
343,761
-49,315
| -13% | -$2.42M | 0.28% | 117 |
|
|
2016
Q2 | $17.6M | Sell |
393,076
-168,175
| -30% | -$7.31M | 0.28% | 119 |
|
|
2016
Q1 | $23M | Sell |
561,251
-162,100
| -22% | -$5.97M | 0.36% | 99 |
|
|
2015
Q4 | $26.4M | Sell |
723,351
-673,126
| -48% | -$24.3M | 0.4% | 96 |
|
|
2015
Q3 | $45.9M | Buy |
1,396,477
+404,699
| +41% | +$13.6M | 0.62% | 69 |
|
|
2015
Q2 | $36.8M | Sell |
991,778
-399,314
| -29% | -$14.5M | 0.45% | 98 |
|
|
2015
Q1 | $48.7M | Sell |
1,391,092
-300,164
| -18% | -$10.6M | 0.55% | 80 |
|
|
2014
Q4 | $64.4M | Sell |
1,691,256
-89,854
| -5% | -$3.29M | 0.66% | 62 |
|
|
2014
Q3 | $63.2M | Sell |
1,781,110
-157,987
| -8% | -$5.87M | 0.63% | 60 |
|
|
2014
Q2 | $75.8M | Buy |
+1,939,097
| New | +$72.4M | 0.61% | 58 |
|
Other funds holding XYL
VCM
VPM
Cramer Rosenthal McGlynn's XYL Position: Q1 2026 in Review
Cramer Rosenthal McGlynn increased its Xylem (XYL) stake by 1.2% in Q1 2026, buying an estimated $217K and bringing the position to 137,562 shares worth $16.4M. The position accounts for 1.21% of the portfolio, ranked #33.
Cramer Rosenthal McGlynn first reported a position in XYL in Q2 2014 and has held it in 31 quarters since. The position peaked at $75.8M in Q2 2014. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.
- Cramer Rosenthal McGlynn held 137,562 shares of Xylem worth $16.4M as of Q1 2026.
- Cramer Rosenthal McGlynn bought 1,653 Xylem shares in Q1 2026, an estimated $217K.
- Xylem made up 1.21% of Cramer Rosenthal McGlynn's portfolio in Q1 2026, its #33 holding.
- Cramer Rosenthal McGlynn first reported a position in Xylem in Q2 2014 and has held it in 31 quarters since.
- Cramer Rosenthal McGlynn's Xylem position peaked at $75.8M in Q2 2014.
- 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.
Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2026, filed 15 May 2026.